Karihtala P - Search Results

1

Survival after breast cancer in women with type 2 diabetes using antidiabetic medication and statins: a retrospective cohort study.

Hosio M, Urpilainen E, Hautakoski A, Marttila M, Arffman M, Sund R, Ahtikoski A, Puistola U, Karihtala P, Jukkola A, Läärä E. Hosio M, et al. Among authors: karihtala p. Acta Oncol. 2020 Sep;59(9):1110-1117. doi: 10.1080/0284186X.2020.1769858. Epub 2020 Jun 1. Acta Oncol. 2020. PMID: 32478629

2

DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma.

Karihtala P, Soini Y, Vaskivuo L, Bloigu R, Puistola U. Karihtala P, et al. Int J Gynecol Cancer. 2009 Aug;19(6):1047-51. doi: 10.1111/IGC.0b013e3181ad0f0d. Int J Gynecol Cancer. 2009. PMID: 19820366

3

8-Hydroxydeoxyguanosine: a new potential independent prognostic factor in breast cancer.

Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P. Sova H, et al. Among authors: karihtala p. Br J Cancer. 2010 Mar 16;102(6):1018-23. doi: 10.1038/sj.bjc.6605565. Epub 2010 Feb 23. Br J Cancer. 2010. PMID: 20179711 Free PMC article.

4

Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis.

Pylväs M, Puistola U, Kauppila S, Soini Y, Karihtala P. Pylväs M, et al. Among authors: karihtala p. Eur J Cancer. 2010 Jun;46(9):1661-7. doi: 10.1016/j.ejca.2010.02.006. Epub 2010 Mar 4. Eur J Cancer. 2010. PMID: 20206498

5

Front-line bevacizumab in serous epithelial ovarian cancer: biomarker analysis of the FINAVAST trial.

Karihtala P, Mäenpää J, Turpeenniemi-Hujanen T, Puistola U. Karihtala P, et al. Anticancer Res. 2010 Mar;30(3):1001-6. Anticancer Res. 2010. PMID: 20393027 Clinical Trial.

6

Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome.

Sova H, Morin-Papunen L, Puistola U, Karihtala P. Sova H, et al. Among authors: karihtala p. Fertil Steril. 2010 Dec;94(7):2670-3. doi: 10.1016/j.fertnstert.2010.03.049. Epub 2010 Apr 28. Fertil Steril. 2010. PMID: 20430377 Free article.

7

Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.

Pylväs M, Puistola U, Laatio L, Kauppila S, Karihtala P. Pylväs M, et al. Among authors: karihtala p. Anticancer Res. 2011 Apr;31(4):1411-5. Anticancer Res. 2011. PMID: 21508394

8

Divergent behaviour of oxidative stress markers 8-hydroxydeoxyguanosine (8-OHdG) and 4-hydroxy-2-nonenal (HNE) in breast carcinogenesis.

Karihtala P, Kauppila S, Puistola U, Jukkola-Vuorinen A. Karihtala P, et al. Histopathology. 2011 May;58(6):854-62. doi: 10.1111/j.1365-2559.2011.03835.x. Histopathology. 2011. PMID: 21585424

9

Absence of the DNA repair enzyme human 8-oxoguanine glycosylase is associated with an aggressive breast cancer phenotype.

Karihtala P, Kauppila S, Puistola U, Jukkola-Vuorinen A. Karihtala P, et al. Br J Cancer. 2012 Jan 17;106(2):344-7. doi: 10.1038/bjc.2011.518. Epub 2011 Nov 22. Br J Cancer. 2012. PMID: 22108520 Free PMC article.

10

Down-regulation of 8-hydroxydeoxyguanosine and peroxiredoxin II in the pathogenesis of endometriosis-associated ovarian cancer.

Sova H, Kangas J, Puistola U, Santala M, Liakka A, Karihtala P. Sova H, et al. Among authors: karihtala p. Anticancer Res. 2012 Aug;32(8):3037-44. Anticancer Res. 2012. PMID: 22843871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters